Novozymes 9M Adjusted EBITDA Margin Rises to 37.9%
Novozymes’ nine-month 2026 adjusted EBITDA margin rose to 37.9% year on year.
Related stories
Next PLC Raises FY27 Sales View
M impact | EARNINGS | Nov 05, 2026, 07:06 AM UTC
Zacros Reports Six-Month Group Recurring Profit Up 10.2%
Zacros forecast 2026/27 profit growth of 2.4%.
M impact | EARNINGS | Nov 05, 2026, 07:04 AM UTC
SAPEET Raises 2025/26 Parent Recurring Profit Forecast
SAPEET revised its 2025/26 parent recurring profit forecast from the previous forecast to a higher forecast, a reported increase of 46.3%.
L impact | EARNINGS | Nov 05, 2026, 07:04 AM UTC
Thor Explorations Reports Q3 Net Income of USD 47.3 Million
M impact | EARNINGS | Nov 05, 2026, 07:04 AM UTC
Uniform Next Reports Nine-Month Profit and Forecasts Higher 2026 Profit
Uniform Next reported nine-month parent net profit and forecast 2026 profit growth of 15.9%.
M impact | EARNINGS | Nov 05, 2026, 07:04 AM UTC
NAC Revises Six-Month Group Recurring Profit Forecast
NAC revised its six-month group recurring profit forecast downward.
L impact | EARNINGS | Nov 05, 2026, 07:04 AM UTC